Table 5.
Comparison of clinical and laboratory findings in 91 COVID-19 patients in regard to the clinical severity
| Moderate (n=42) | Severe (n=49) | P-value | |
|---|---|---|---|
| Variable | Mean ± SD / N (%) | Mean ± SD / N (%) | |
| Sex (male) | 59.5 | 61. 2 | 0.51 |
| Age (year) | 49.6 ± 15.4 | 60.39 ± 16.7 | 0.02* |
| Hospitalization(day) | 6.66 ± 2.8 | 7.96 ± 3.09 | 0.05 |
| ICU admission | 0 | 42.9 | <0.001 |
| Death | 0 | 29.2 | <0.001 |
| Respiratory rate | 20 ± 4.03 | 22.82 ± 6.66 | 0.03 |
| O2 saturation | 89.07 ± 5.02 | 84.26 ± 12.35 | <0.001* |
| WBC(×109/μL) | 6.74 ± 3.48 | 7.83 ± 5.26 | 0.25 |
| Lymphocyte(×109/μL) | 1.32 ± 0.55 | 1.02 ± 0.58 | 0.01* |
| Hemoglobin(g/dL) male | 15 ± 1.6 | 14.6 ± 1.5 | 0.31 |
| Hemoglobin(g/dL) female | 12.7±1.2 | 12.7±2.2 | 0.8 |
| Albumin(g/dL) | 3.88 ± 0.47 | 3.60 ± 0.48 | 0.007* |
| BUN(mg/dL) | 14 ± 6.89 | 18.55 ± 12.24 | 0.029 |
| Creatinine(mg/dL) male | 0.82 ± 0.15 | 1 ± 0.43 | 0.05 |
| Creatinine(mg/dL) female | 0.71 ±0.12 | 0.94±0.53 | 0.08 |
| Sodium(mmol/L) | 137.5 ± 2.8 | 136.4 ± 3.6 | 0.11 |
| Potassium(mmol/L) | 4.11± 0.38 | 4.05 ± 0.37 | 0.42 |
| Vitamin D(nmol/L) | 70.7 ± 19.2 | 75.2 ± 26.8 | 0.40 |
| PTH(pg/mL) | 43.08 ± 17.2 ± 16.44 |
47.0 ± 27.68 ± 28.01 |
0.47 |
| Calcium (mg/dL) | 8.69 ± 0.41 | 8.08 ± 0.54 | < 0.001* |
*Statistical significance at P-value< 0.05